Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 2697       
SPECIAL REPORT
Year : 2019  |  Volume : 149  |  Issue : 2  |  Page : 164-179

Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far


1 Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India
2 Department of Clinical Microbiology, Christian Medical College, Vellore, India
3 Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
4 Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
5 Division of Informatics, Systems & Research Management, Indian Council of Medical Research, New Delhi, India
6 Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India

Correspondence Address:
Dr Kamini Walia
Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmr.IJMR_226_18

Rights and Permissions

The Indian Council of Medical Research, in 2013, initiated the Antimicrobial Resistance Surveillance & Research Network (AMRSN) to enable compilation of data on six pathogenic groups on antimicrobial resistance from the country. The overarching aim of this network was to understand the extent and pattern of antimicrobial resistance (AMR) and use this evidence to guide strategies to control the spread of AMR. This article describes the conception and implementation of this AMR surveillance network for India. Also described are the challenges, limitations and benefits of this approach. Data from the Network have shown increasing resistance in Gram-negative bacteria in the hospitals that are part of this network. Combined resistance to third-generation cephalosporins and fluoroquinolones and increasing carbapenem resistance are worrisome, as it has an important bearing on the patients' outcome and thus needs to be addressed urgently. Data generated through this Network have been used to develop treatment guidelines, which will be supportive in harmonizing treatment practices across the tertiary level healthcare institutions in the country. While, the major benefit of having a surveillance system is the collection of real-time accurate data on AMR including the mechanisms of resistance, representativeness to community, sustaining the current effort and expanding the current activities to next levels of healthcare settings are the major challenges. The data emanating from the network besides providing evidence, expose several gaps and lacunae in the ecosystem and highlight opportunities for action by multiple stakeholders.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1605    
    Printed2    
    Emailed0    
    PDF Downloaded400    
    Comments [Add]    
    Cited by others 1    

Recommend this journal